Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

greenovation Biotech Strengthens Corporate Management

Published: Wednesday, May 07, 2014
Last Updated: Wednesday, May 07, 2014
Bookmark and Share
Company appoints Andreas Hartmann as the new Chief Business Officer.

greenovation Biotech GmbH welcomes Andreas Hartmann, Ph.D. as the new Chief Business Officer. Prior to joining greenovation Dr. Hartmann established and managed the German operations for Therabel and Emergent BioSolutions and held local as well as international management, business development and marketing & sales positions at Emergent BioSolutions, Bavarian Nordic, Ares Serono, Sanofi-Winthrop and Janssen-Cilag.

With greenovation having passed the strategic turning point from an expression platform developer and service provider towards developing customized protein biopharmaceuticals, Dr. Hartmann will intensify the company's international efforts in establishing developmental collaborations and out-licensing/partnering of its advanced lead candidates and selected programs.

greenovation's proprietary Physcomitrella-based BryoTechnology™-platform is suitable for expressing complex multi-purpose proteins. In line with streamlining the business focus the BryoTechnology™-platform has now preferentially been dedicated to development and production of demanding proteins for pharmaceutical use.

The company's lead candidates, targeting unmet medical needs in orphan indications, are spearheaded by recombinant moss Alpha-Galactosidase, to be developed as enzyme-replacement Therapy (ERT) for patients with Fabry Disease. The pre-clinical development of moss Alpha-Galactosidase is close to being completed. With GMP-manufacturing and protein analytics having been fully established greenovation is confident to move this first ever moss-expressed biopharmaceutical candidate into clinical development in autumn 2014.

“We are pleased to welcome Dr. Hartmann to join greenovation's management team. His appointment underlines the company's recent clear cut specialization in biopharmaceuticals. Dr. Hartmann's extensive executive and hands-on operational knowledge and experience in international (bio)pharmaceutical industry makes him ideally qualified to help further developing and achieving greenovation's business goals and future progress", said Günter Steffen, Chairman of greenovation's Advisory Board.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!